申请人:CUI Jingrong Jean
公开号:US20140288086A1
公开(公告)日:2014-09-25
Enantiomerically pure compound of formula 1
are provided, as well as methods for their synthesis and use. Preferred compounds are potent inhibitors of the c-Met protein kinase, and are useful in the treatment of abnormal cell growth disorders, such as cancers.
本发明提供了公式1的对映纯化合物,以及它们的合成和使用方法。首选化合物是c-Met蛋白激酶的强效抑制剂,可用于治疗异常细胞增生性疾病,例如癌症。